Skip to content

A study of the QuXie capsul in the treatment of advanced colorectal cancer

A study of the QuXie capsul in the treatment of advanced colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008924
Enrollment
Unknown
Registered
2016-07-27
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Advanced colorectal cancer

Interventions

treatment group:Qu Xie Jiao Nang+conventional treatment
control groups:conventional treatment

Sponsors

Xiyuan Hospital, China Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patients with colorectal cancer have the pathological diagnosis; 2. The TNM is 4 stage, postoperative rerecurrence or who missed the chance of operation that didnt make surgery; 3. The age between 18-80 years old, Sex unlimited; 4. The expected survival time is more than half year; 5. Have no serious functional abnormity of heart, liver, or kidney; 6. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Merging other manignant turmors, except the curative skin basal cell carcinoma or the carcinoma in situ of cervix; 2. Merging the serious complication of heart,liver,and kidney; 3. The patient have ileus and couldnt take the decoction of medicinal ingredients,who need the intravenous nutrition. The patient who have the malabsorption syndrome, other diseases which affect the intestinal absorption kinetics, or active peptic ulcer disease; 4. Any unsettled condition or other conditions that can endangered patient security or their obedience; 5. The researcher predicte the patients lifetime which lower half ayear with their clinical experience; 6. The subject who are regard as with poor compliance that couldnt complete the research.

Design outcomes

Primary

MeasureTime frame
immune function;

Countries

China

Contacts

Public ContactYUFEI YANG

Xiyuan Hospital, China Academy of Traditional Chinese Medicine

yyf93@vip.sina.com+86 13701366913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026